Shenzhen Transsion Holdings Co., Ltd. (688036.SH): The final H-share offering price is HK$35.30 per share.
Shenzhen Transsion Holdings Co., Ltd. (688036.SH) announced that the company is in the process of applying for the issuance of overseas-listed shares (H shares) and listing on the Main Board of the Hong Kong Stock Exchange. The company has determined that the final offering price for this H-share issuance is HK$35.30 per share (excluding a 1% brokerage commission, a 0.0027% Hong Kong Securities and Futures Commission transaction levy, a 0.00565% Hong Kong Stock Exchange trading fee, and a 0.00015% Hong Kong Accounting and Financial Reporting Council transaction levy). The H shares issued by the company this time are expected to be listed on the Main Board of the Hong Kong Stock Exchange and commence trading on October 15, 2026.
Shenzhen Transsion Holdings Co., Ltd. (688036.SH) announced that the company is carrying out the relevant work for the application for the issuance of overseas-listed shares (H shares) and listing on the Main Board of the Hong Kong Stock Exchange. The company has determined that the final price for this H-share offering is HK$35.30 per share (excluding a 1% brokerage commission, a 0.0027% Hong Kong Securities and Futures Commission transaction levy, a 0.00565% Hong Kong Stock Exchange trading fee, and a 0.00015% Hong Kong Accounting and Financial Reporting Council transaction levy). The H shares issued by the company in this offering are expected to be listed on the Main Board of the Hong Kong Stock Exchange and commence listing and trading on October 15, 2026.
Related Articles

SBP GROUP (01177): TQ-A3334 "TLR7 agonist" and TQA3605 "core protein allosteric modulator" granted Breakthrough Therapy Designation by CDE

CHINAGOLDINTL (02099): Jiama Mine Operations Unaffected by Earthquake and Annual Production Guidance Reiterated

SANDS CHINA LTD (01928): Proposed Issuance of Senior Notes
SBP GROUP (01177): TQ-A3334 "TLR7 agonist" and TQA3605 "core protein allosteric modulator" granted Breakthrough Therapy Designation by CDE

CHINAGOLDINTL (02099): Jiama Mine Operations Unaffected by Earthquake and Annual Production Guidance Reiterated

SANDS CHINA LTD (01928): Proposed Issuance of Senior Notes






